Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Teramura

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Biotherapy (Dordrecht, Netherlands)|January 1, 1992
Therapeutic and life-prolonging effect of intrapleural injection with a streptococcal preparation, OK-432, and IL2-cultured effusion lymphocytes to breast cancer patients with malignant pleural effusionT Hori, K Mise, N Kan, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1990
The therapeutic effect of OK-432-combined adoptive immunotherapy against liver metastases from breast cancerT Okino, N Kan, M Nakanishi, et al.
Nihon Gan Chiryo Gakkai Shi|March 20, 1990
[Adoptive immunotherapy against peritoneal metastases from stomach cancer--application of regional lymph node lymphocytes]T Okino, N Kan, K Mise, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1989
[The therapeutic effects of OK-432 combined adoptive immunotherapy (AIT) against liver metastases of breast cancer]T Okino, N Kan, M Nakanishi, et al.
International Journal of Oncology|May 10, 2011
Rejection of parental meth-a tumor on concomitant inoculation of meth-a cells infected retrovirally with the interferon-gamma gene into (balb/cxc57bl/6)f-1 miceM Harutsumi, T Aji, A Manki, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1992
Factors influencing the response and survival of patients with liver metastases from breast cancer receiving OK-432-combined adoptive immunotherapyS Yamasaki, T Okino, N Kan, et al.
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|October 1, 1996
Establishment and evaluation of a new chemiluminescent enzyme immunoassay for carcinoembryonic antigen adapted to the fully automated ACCESS systemH Matsushita, J Xu, M Kuroki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1989
[Experimental and clinical study of adoptive immunotherapy combined with preadministration of OK-432: a method to augment the therapeutic effect]N Kan, T Okino, M Nakanishi, et al.
Surgery Today|January 1, 1997
The effectiveness of active specific immunotherapy using interferon-gamma-gene-transduced tumor cells in a murine tumor modelY Moriguchi, N Kan, T Okino, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Biotherapy (Dordrecht, Netherlands)|January 1, 1992
Therapeutic and life-prolonging effect of intrapleural injection with a streptococcal preparation, OK-432, and IL2-cultured effusion lymphocytes to breast cancer patients with malignant pleural effusionT Hori, K Mise, N Kan, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1990
The therapeutic effect of OK-432-combined adoptive immunotherapy against liver metastases from breast cancerT Okino, N Kan, M Nakanishi, et al.
Nihon Gan Chiryo Gakkai Shi|March 20, 1990
[Adoptive immunotherapy against peritoneal metastases from stomach cancer--application of regional lymph node lymphocytes]T Okino, N Kan, K Mise, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1989
[The therapeutic effects of OK-432 combined adoptive immunotherapy (AIT) against liver metastases of breast cancer]T Okino, N Kan, M Nakanishi, et al.
International Journal of Oncology|May 10, 2011
Rejection of parental meth-a tumor on concomitant inoculation of meth-a cells infected retrovirally with the interferon-gamma gene into (balb/cxc57bl/6)f-1 miceM Harutsumi, T Aji, A Manki, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1992
Factors influencing the response and survival of patients with liver metastases from breast cancer receiving OK-432-combined adoptive immunotherapyS Yamasaki, T Okino, N Kan, et al.
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|October 1, 1996
Establishment and evaluation of a new chemiluminescent enzyme immunoassay for carcinoembryonic antigen adapted to the fully automated ACCESS systemH Matsushita, J Xu, M Kuroki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1989
[Experimental and clinical study of adoptive immunotherapy combined with preadministration of OK-432: a method to augment the therapeutic effect]N Kan, T Okino, M Nakanishi, et al.
Surgery Today|January 1, 1997
The effectiveness of active specific immunotherapy using interferon-gamma-gene-transduced tumor cells in a murine tumor modelY Moriguchi, N Kan, T Okino, et al.
Pageof 3